Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Operating Expenses | 8,156 | 4,141 | 4,689 | 4,433 | 4,448 |
| Operating Income | -8,156 | -4,141 | -4,689 | -4,433 | -4,448 |
| Interest Expense | 4 | 4 | 4 | 4 | 4 |
| Other Income | 14 | 24 | 13 | 12 | 130 |
| Pre-tax Income | -8,147 | -4,121 | -4,680 | -4,425 | -4,322 |
| Net Income Continuous | -8,147 | -4,121 | -4,680 | -4,425 | -4,322 |
| Net Income | $-8,147 | $-4,121 | $-4,680 | $-4,425 | $-4,322 |
| EPS Basic Total Ops | -3.75 | -1.50 | -2.75 | -3.25 | -3.75 |
| EPS Basic Continuous Ops | -3.66 | -1.46 | -2.81 | -3.22 | -3.70 |
| EPS Diluted Total Ops | -3.75 | -1.50 | -2.75 | -3.25 | -3.75 |
| EPS Diluted Continuous Ops | -3.66 | -1.46 | -2.81 | -3.22 | -3.70 |
| EBITDA(a) | $-8,117 | $-4,102 | $-4,658 | $-4,386 | $-4,413 |